These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 28451914

  • 1. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M.
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R, Schulz C, Schweden M, Casèn C, Kirubakaran GT, Kirste KH, Macke L, Link A, Schütte K, Malfertheiner P.
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [Abstract] [Full Text] [Related]

  • 6. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome.
    Zaki MES, Elhammady D, Foda Salama M, Abdelsalam M, Osman AOB.
    F1000Res; 2021 Dec; 10():303. PubMed ID: 34754418
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico.
    Schmulson M, Balbuena R, Corona de Law C.
    Rev Gastroenterol Mex; 2016 Dec; 81(4):236-239. PubMed ID: 27681080
    [Abstract] [Full Text] [Related]

  • 8. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
    Morales W, Triantafyllou K, Parodi G, Weitsman S, Park SC, Rezaie A, Pichetshote N, Lin E, Pimentel M.
    Neurogastroenterol Motil; 2020 Oct; 32(10):e13875. PubMed ID: 32436301
    [Abstract] [Full Text] [Related]

  • 9. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B.
    World J Gastroenterol; 2015 Jul 14; 21(26):8103-9. PubMed ID: 26185382
    [Abstract] [Full Text] [Related]

  • 10. Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model.
    Leite G, de Freitas Germano J, Morales W, Weitsman S, Barlow GM, Parodi G, Pimentel ML, Villanueva-Millan MJ, Sanchez M, Ayyad S, Rezaie A, Mathur R, Pimentel M.
    Gut Microbes; 2024 Jul 14; 16(1):2293170. PubMed ID: 38108386
    [Abstract] [Full Text] [Related]

  • 11. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
    Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y.
    J Clin Gastroenterol; 2016 Mar 14; 50(3):227-32. PubMed ID: 25930973
    [Abstract] [Full Text] [Related]

  • 12. Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
    Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, Chua KS, Srinivasan S, Barlow GM, Chang C.
    Dig Dis Sci; 2015 May 14; 60(5):1195-205. PubMed ID: 25424202
    [Abstract] [Full Text] [Related]

  • 13. A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome.
    Pimentel M, Purdy C, Magar R, Rezaie A.
    Clin Ther; 2016 Jul 14; 38(7):1638-1652.e9. PubMed ID: 27261204
    [Abstract] [Full Text] [Related]

  • 14. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q.
    J Gastroenterol Hepatol; 2012 Apr 14; 27(4):760-5. PubMed ID: 21929652
    [Abstract] [Full Text] [Related]

  • 15. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD.
    Gastroenterology; 2019 Sep 14; 157(3):859-880. PubMed ID: 31351880
    [Abstract] [Full Text] [Related]

  • 16. No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection.
    Hanevik K, Saghaug C, Aaland M, Morch K, Langeland N.
    JGH Open; 2022 Mar 14; 6(3):185-188. PubMed ID: 35355666
    [Abstract] [Full Text] [Related]

  • 17. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct 14; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 18. [An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome].
    Shi H, Wan J, Liu W, Su B.
    Zhonghua Nei Ke Za Zhi; 2015 Apr 14; 54(4):326-9. PubMed ID: 26268062
    [Abstract] [Full Text] [Related]

  • 19. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P, Silvester J, Chen X, Xu H, Sawhney V, Rangan V, Iturrino J, Nee J, Duerksen DR, Lembo A.
    United European Gastroenterol J; 2019 Jun 14; 7(5):709-715. PubMed ID: 31210949
    [Abstract] [Full Text] [Related]

  • 20. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R, Abbasnezhad A, Amani R, Alipour M.
    Dig Dis Sci; 2017 Jun 14; 62(6):1550-1560. PubMed ID: 28374085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.